Clinical Trial

INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 22, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
INNOVEN is a multi-center randomized controlled clinical trial to evaluate the efficacy of porcine placental extracellular matrix (PPECM) and standard of care (SOC) versus SOC alone in the closure of non-healing venous leg ulcers (VLUs).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-09-18; most recent amendment 2025-08-21.
Status change: Not Yet Recruiting → Recruiting 2024-09-23
Trial Details
NCT Number NCT06606210
Lead Sponsor ConvaTec Inc.
Conditions Wound Heal, Venous Leg Ulcer
Enrollment 120 participants
Start Date 2024-09-19
Primary Completion 2025-12 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2025-08-22